PÁNCREAS ARTIFICIAL: ALGORITMO EN DIABETES MELLITUS TIPO 1

Daniel Cherniavsky

Resumen


Avances realizados en el área de la investigación clínica en el uso del páncreas artificial para el tratamiento de la diabetes mellitus tipo 1 (DM1), así como su uso clínico y futuras aplicaciones en la DM2.


Palabras clave


Páncreas; diabetes.

Texto completo:

PDF

Referencias


Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Cherñavvsky DR, et. al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013 Jul; 36(7):1851-8. PMCID: PMC3687268.

Cherñavvsky DR, DeBoer MD, et al. Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes 2016 Feb; 17(1):28-35.

Ly TT, Buckingham BA, DeSalvo DJ, Shanmugham S, Satin-Smith M, DeBoer MD, Oliveri MC, Schertz E, Breton MD, Cherñavvsky DR. Day and night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care 2016 Jun 6. PMID: 27271182.

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky DR. Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial. Diabetes Technol & Ther 2019 Mar 19.




DOI: http://dx.doi.org/10.47196/diab.v53i2Sup.225